Cladribine, cytarabine, and GCSF with and without mitoxantrone (CLAG ± M) is highly effective for poor risk acute myeloid leukemia with adverse karyotype and prior hypomethylating therapy
Leuk Lymphoma. 2021 Jul;62(7):1778-1781.
doi: 10.1080/10428194.2021.1885654.
Epub 2021 Feb 16.